First Quadrant L P CA Buys Shares of 44,537 Castlight Health Inc (CSLT)

First Quadrant L P CA bought a new position in Castlight Health Inc (NYSE:CSLT) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 44,537 shares of the software maker’s stock, valued at approximately $167,000.

Other institutional investors have also recently modified their holdings of the company. Citadel Advisors LLC lifted its stake in Castlight Health by 37.8% in the 3rd quarter. Citadel Advisors LLC now owns 144,936 shares of the software maker’s stock worth $623,000 after purchasing an additional 39,766 shares in the last quarter. Swiss National Bank lifted its stake in Castlight Health by 173.3% in the 3rd quarter. Swiss National Bank now owns 108,350 shares of the software maker’s stock worth $466,000 after purchasing an additional 68,700 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Castlight Health by 52.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 222,660 shares of the software maker’s stock worth $924,000 after purchasing an additional 77,011 shares in the last quarter. Gagnon Securities LLC lifted its stake in Castlight Health by 3.3% in the 3rd quarter. Gagnon Securities LLC now owns 1,484,726 shares of the software maker’s stock worth $6,384,000 after purchasing an additional 47,398 shares in the last quarter. Finally, California State Teachers Retirement System lifted its stake in Castlight Health by 39.7% in the 2nd quarter. California State Teachers Retirement System now owns 113,399 shares of the software maker’s stock worth $471,000 after purchasing an additional 32,200 shares in the last quarter. 42.51% of the stock is owned by institutional investors.

Shares of Castlight Health Inc (NYSE CSLT) opened at $3.70 on Friday. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.03. Castlight Health Inc has a 1 year low of $3.05 and a 1 year high of $4.75.

Castlight Health (NYSE:CSLT) last announced its earnings results on Wednesday, October 25th. The software maker reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.02. The firm had revenue of $34.60 million for the quarter, compared to analysts’ expectations of $34.61 million. Castlight Health had a negative net margin of 45.14% and a negative return on equity of 32.57%. The business’s revenue was up 35.7% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.05) EPS. equities research analysts forecast that Castlight Health Inc will post -0.43 earnings per share for the current year.

In related news, CFO Mangini Siobhan Nolan sold 8,866 shares of the stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.70, for a total value of $32,804.20. Following the sale, the chief financial officer now directly owns 78,561 shares of the company’s stock, valued at approximately $290,675.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO John C. Doyle sold 13,686 shares of the stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $3.71, for a total transaction of $50,775.06. Following the completion of the sale, the chief executive officer now directly owns 123,705 shares in the company, valued at $458,945.55. The disclosure for this sale can be found here. Insiders have sold a total of 22,778 shares of company stock worth $84,411 over the last 90 days. Corporate insiders own 37.43% of the company’s stock.

CSLT has been the topic of several research analyst reports. Cantor Fitzgerald reiterated a “hold” rating and issued a $5.00 price target on shares of Castlight Health in a research note on Wednesday, October 25th. Chardan Capital decreased their price target on shares of Castlight Health from $6.50 to $6.30 and set a “buy” rating on the stock in a research note on Thursday, October 26th. Zacks Investment Research cut shares of Castlight Health from a “buy” rating to a “hold” rating in a research note on Monday, January 1st. BidaskClub cut shares of Castlight Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, November 9th. Finally, Canaccord Genuity restated a “buy” rating and set a $7.00 target price on shares of Castlight Health in a research report on Thursday, October 26th. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $5.11.

TRADEMARK VIOLATION WARNING: “First Quadrant L P CA Buys Shares of 44,537 Castlight Health Inc (CSLT)” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://transcriptdaily.com/2018/02/02/first-quadrant-l-p-ca-buys-shares-of-44537-castlight-health-inc-cslt.html.

Castlight Health Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Institutional Ownership by Quarter for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply